Sign in
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Journal article   Open access  Peer reviewed

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Jing Quan Lim, Dachuan Huang, Tiffany Tang, Daryl Tan, Yurike Laurensia, Rou-Jun Peng, Esther Kam Yin Wong, Daryl Ming Zhe Cheah, Burton Kuan Hui Chia, Jabed Iqbal, …
Leukemia, Vol.34(12), pp.3413-3419
01/12/2020
PMCID: 7685978
PMID: 32753688

Abstract

Adult Aged Antibodies, Monoclonal, Humanized - therapeutic use Female Humans Killer Cells, Natural - drug effects Lymphoma, T-Cell - drug therapy Lymphoma, T-Cell - genetics Male Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - genetics Whole Genome Sequencing - methods
url
https://doi.org/10.1038/s41375-020-1000-0View
Published (Version of record) Open

Details